Ligand Pharm (LGND) Stock Price, Quote & News

Company Profile

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI, a dual endothelin and angiotensin II receptor antagonist for immunoglobulin A nephropathy; Ohtuvayre for respiratory disease; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pn...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 550 7500

Website: www.ligand.com

Address:

555 Heritage Drive, Suite 200, Jupiter, United States

Doozio Aug. 5 at 11:28 PM

$LGND s of the fall. 🐒🍌🧠⏰♾️

0 · Reply

FannyPackin Aug. 5 at 11:26 PM

$LGND 160 this fall?

0 · Reply

Doozio Aug. 5 at 8:50 PM

$XBI has gotten its RYTM and they supported it in $HRMY as da $HALO gaps n GOGO’s to protect YO as its about to get fookin $LGND ary NEXT as the 🧠 spreads 🐒🍌🧠⏰♾️

0 · Reply

CryptoSenderX Jul. 25 at 8:28 AM

$PTHS 🪐 . Low Cap with $60 price target analysis . 600k Shares Free Float I OS Locked Up . Backed by $LGND ( 50% Stake in the Company ) . Commercialising the only FDA Approved Product The next $DRUG I $RGC I $STEC I is here 🎆 Always do your own DD 👌🏻

0 · Reply

CryptoSenderX Jul. 24 at 12:56 PM

$LGND own a 56% stake in $PTHS

0 · Reply

Doozio Jul. 24 at 10:30 AM

$XBI wen all da $DRUG zzzz go in $RYTM and $HRMY n this gets $LGND ary in 🐒🍌🧠⏰♾️

0 · Reply

Doozio Jul. 19 at 1:20 AM

YO this 💩 has officially gotten $LGND ary during 🐒🍌🧠⏰♾️

0 · Reply

Trade4Profits007 Jul. 11 at 10:12 PM

$PTHS $LGND owns 49% of the stock. Ligand CEO stated “We look forward to more exciting developments from Pelthos in the coming months”. - More news coming soon

1 · Reply

StocktwitsNews Jul. 11 at 2:22 AM

Pelthos, Ligand Gain After Launch Of First Prescription-At-Home Treatment For Water Warts $PTHS $LGND https://stocktwits.com/news/equity/markets/pelthos-ligand-gain-after-launch-of-first-prescription-at-home-treatment-for-water-warts/ch8TDAvR5lI

0 · Reply

StockPortfolioManager Jul. 9 at 4:08 PM

🚀 3 Safe Stocks Surging Today: $FUTU, $AES & $LGND – Long-Term Winners! Looking for stocks with strong growth AND stability? Here are 3 top picks: 🔥 Futu Holdings (FUTU) – Fintech leader with +87% in a year! 💡 AES Corp (AES) – Undervalued utility stock (+17% today). 💊 Ligand Pharma (LGND) – Steady biotech play with a solid pipeline. Why invest? ✅ Strong market caps (2B-19B) ✅ Mix of growth & stability ✅ Surging today but built for long-term gains Perfect for a balanced portfolio! 💰

0 · Reply

Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed

MDT OBIO

Jul 24, 2025, 7:00 AM EDT - 13 days ago

Ligand to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 10, 2025, 8:00 AM EDT - 27 days ago

Ligand Partner Pelthos Therapeutics Launches ZELSUVMI™

Jul 2, 2025, 7:00 AM EDT - 5 weeks ago

Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement

Jul 2, 2025, 7:00 AM EDT - 5 weeks ago

Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics

Jun 24, 2025, 2:47 PM EDT - 6 weeks ago

Ligand Pharmaceuticals: Attractive Royalty Model Powers Forward

Jun 11, 2025, 7:00 AM EDT - 2 months ago

Ligand Announces 2025 Investor Day in New York City

May 14, 2025, 7:00 AM EDT - 3 months ago

Ligand to Ring the Nasdaq Opening Bell on May 19, 2025

May 8, 2025, 2:19 PM EDT - 3 months ago

Ligand Pharmaceuticals Incorporated (LGND) Q1 2025 Earnings Call Transcript

May 8, 2025, 7:00 AM EDT - 3 months ago

Ligand Reports First Quarter 2025 Financial Results

May 1, 2025, 7:00 AM EDT - 3 months ago

Ligand to Participate in May Investor Conferences

Apr 24, 2025, 7:00 AM EDT - 3 months ago

Ligand to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 17, 2025, 6:00 AM EDT - 3 months ago

Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics

Mar 3, 2025, 7:00 AM EST - 5 months ago

Ligand to Participate in March Investor Conferences

Feb 27, 2025, 3:06 PM EST - 5 months ago

Ligand Pharmaceuticals Incorporated (LGND) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 7:00 AM EST - 5 months ago

Ligand Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 25, 2025, 7:00 AM EST - 5 months ago

Ligand Leads $75 Million Royalty Financing in Castle Creek Biosciences

XOMA

Feb 13, 2025, 7:00 AM EST - 6 months ago

Ligand to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

Feb 6, 2025, 7:00 AM EST - 6 months ago

Ligand to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Feb 3, 2025, 2:59 PM EST - 6 months ago

Looking Back On Ligand Pharmaceuticals

Jan 13, 2025, 6:10 PM EST - 7 months ago

Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025

ABBV AMGN AZN BNTX FBCG GILD GSK

Dec 10, 2024, 9:00 AM EST - 8 months ago

Ligand Hosts 2024 Investor and Analyst Day and Introduces 2025 Guidance

Nov 24, 2024, 6:50 AM EST - 9 months ago

Ligand Pharmaceuticals: Buy This Strong Growing Pharma And Get A Stake In Dozens Of Therapies

Nov 14, 2024, 8:00 AM EST - 9 months ago

Ligand to Present at Stifel 2024 Healthcare Conference

Nov 8, 2024, 8:07 AM EST - 9 months ago

Ligand Pharmaceuticals Incorporated (LGND) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 7:00 AM EST - 9 months ago

Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance

Nov 1, 2024, 8:01 AM EDT - 9 months ago

Ligand to Host Investor and Analyst Day on December 10, 2024 in Boston

Oct 23, 2024, 4:01 PM EDT - 10 months ago

Ligand to Report Third Quarter 2024 Financial Results on November 7, 2024

Sep 6, 2024, 9:20 AM EDT - 11 months ago

Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy

TVTX

Aug 30, 2024, 4:04 AM EDT - 1 year ago

CD40 Ligand Market - Global Monoclonal Antibody, Polyclonal Antibody, Autoimmune Disease Treatment, Immunotherapy, Vaccine Development Forecast 2024-2030

Aug 20, 2024, 9:00 AM EDT - 1 year ago

Ligand to Present at H.C. Wainwright 26th Annual Global Investment Conference

Aug 6, 2024, 10:58 PM EDT - 1 year ago

Ligand Pharmaceuticals Incorporated (LGND) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 4:01 PM EDT - 1 year ago

Ligand Reports Second Quarter 2024 Financial Results

Jul 29, 2024, 2:43 PM EDT - 1 year ago

Ligand Pharmaceuticals: Solid Performer Performing Solidly

Jul 24, 2024, 6:30 AM EDT - 1 year ago

Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement

Jul 23, 2024, 4:01 PM EDT - 1 year ago

Ligand to Report Second Quarter 2024 Financial Results on August 6, 2024

Jul 8, 2024, 7:00 AM EDT - 1 year ago

Ligand to Acquire APEIRON Biologics AG for $100 Million

Jun 27, 2024, 8:00 AM EDT - 1 year ago

Ligand Partner Verona Pharma Announces FDA Approval of Ohtuvayre™ (ensifentrine), First Inhaled Novel Mechanism for Maintenance Treatment of COPD in More Than 20 Years

Jun 18, 2024, 8:00 AM EDT - 1 year ago

Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults

May 23, 2024, 4:59 PM EDT - 1 year ago

Ligand to Participate in Upcoming Investor Conferences

May 7, 2024, 11:03 PM EDT - 1 year ago

Ligand Pharmaceuticals Incorporated (LGND) Q1 2024 Earnings Call Transcript

May 7, 2024, 4:00 PM EDT - 1 year ago

Ligand Reports First Quarter 2024 Financial Results

May 7, 2024, 7:30 AM EDT - 1 year ago

Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement

AGEN

Apr 29, 2024, 10:01 PM EDT - 1 year ago

Ligand: Buy This Pharma Royalty Aggregator To Generate Growth In Your Portfolio

Apr 23, 2024, 8:31 AM EDT - 1 year ago

Ligand to Report First Quarter 2024 Financial Results on May 7, 2024

Apr 8, 2024, 8:15 AM EDT - 1 year ago

Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference

Apr 3, 2024, 9:00 AM EDT - 1 year ago

Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™

Mar 5, 2024, 4:01 PM EST - 1 year ago

Ligand Pharmaceuticals to Present at Barclays 26th Annual Global Healthcare Conference

Mar 4, 2024, 8:00 AM EST - 1 year ago

Ligand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feb 27, 2024, 11:32 AM EST - 1 year ago

Ligand Pharmaceuticals Inc. (LGND) Q4 2023 Earnings Call Transcript

Doozio Aug. 5 at 11:28 PM

$LGND s of the fall. 🐒🍌🧠⏰♾️

0 · Reply

FannyPackin Aug. 5 at 11:26 PM

$LGND 160 this fall?

0 · Reply

Doozio Aug. 5 at 8:50 PM

$XBI has gotten its RYTM and they supported it in $HRMY as da $HALO gaps n GOGO’s to protect YO as its about to get fookin $LGND ary NEXT as the 🧠 spreads 🐒🍌🧠⏰♾️

0 · Reply

CryptoSenderX Jul. 25 at 8:28 AM

0 · Reply

CryptoSenderX Jul. 24 at 12:56 PM

$LGND own a 56% stake in $PTHS

0 · Reply

Doozio Jul. 24 at 10:30 AM

$XBI wen all da $DRUG zzzz go in $RYTM and $HRMY n this gets $LGND ary in 🐒🍌🧠⏰♾️

0 · Reply

Doozio Jul. 19 at 1:20 AM

YO this 💩 has officially gotten $LGND ary during 🐒🍌🧠⏰♾️

0 · Reply

Trade4Profits007 Jul. 11 at 10:12 PM

$PTHS $LGND owns 49% of the stock. Ligand CEO stated “We look forward to more exciting developments from Pelthos in the coming months”. - More news coming soon

1 · Reply

StocktwitsNews Jul. 11 at 2:22 AM

0 · Reply

StockPortfolioManager Jul. 9 at 4:08 PM

0 · Reply

Doozio Jul. 9 at 12:33 PM

Gap n GOGO’s with da huckleberries thru da $$$ get in $RYTM NOW TTWO BYRN da 🐑! if $KWEB can join this 🎉 its gonna a get $LGND ary out of the tightness 🐒🍌🧠⏰♾️

0 · Reply

Estimize Jul. 7 at 7:02 PM

Wall St is expecting 1.42 EPS for $LGND Q2 [Reporting 08/11 BMO] http://www.estimize.com/intro/lgnd?chart=historical&metric_name=eps&utm_co

0 · Reply

ISHARETRADEALERTS Jul. 7 at 3:11 PM

$PTHS $LGND Pelthos Therapeutics 13D Filing Shows Ligand Pharmaceuticals Discloses 49.9% Stake As Of July 1, 2025

0 · Reply

Doozio Jul. 4 at 5:01 PM

$LGND s are made out of the tightness in $RYTM during 🐒🍌🧠⏰♾️

0 · Reply

Doozio Jul. 1 at 4:28 PM

$XBI is finding its $RYTM in $HRMY and its about TTWO get $LGND ry during 🐒🍌🧠⏰♾️

1 · Reply

Estimize Jun. 30 at 1:00 PM

Wall St is expecting 1.42 EPS for $LGND Q2 [Reporting 08/11 BMO] http://www.estimize.com/intro/lgnd?chart=historical&metric_name=eps&utm_co

0 · Reply

WAJeff Jun. 26 at 11:22 PM

$LGND Lost track of this one since the $60S in 2023. Can’t own ‘em all, I guess.

0 · Reply

Estimize Jun. 23 at 11:00 PM

Wall St is expecting 1.42 EPS for $LGND Q2 [Reporting 08/11 BMO] http://www.estimize.com/intro/lgnd?chart=historical&metric_name=eps&utm_co

0 · Reply

Doozio Jun. 20 at 2:19 PM

The $LGCY of 🐒🍌🧠⏰♾️ will be $LGND ary if $XBI can ever get in $RYTM with da huckleberries in $HRMY

0 · Reply

swingingtech Jun. 9 at 9:03 PM

$LGND https://wallstreetwaves.com/lgnd-surpasses-key-moving-average-with-bullish-momentum/

0 · Reply

Estimize Jun. 9 at 1:01 PM

Wall St is expecting 1.42 EPS for $LGND Q2 [Reporting 08/11 BMO] http://www.estimize.com/intro/lgnd?chart=historical&metric_name=eps&utm_co

0 · Reply

SmartInsider May. 20 at 10:53 AM

Ligand Pharmaceuticals Inc - $LGND US ranked positive on May 14th, 2025 Learn more: https://www.smartinsider.com/stock-of-the-week/lgnd-us-ranked-positive-on-may-14th-2025/

0 · Reply

Market Cap	2.61B
Revenue (ttm)	167.13M
Net Income (ttm)	-4.03M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	971.12
Profit Margin	-2.41%
Debt to Equity Ratio	0.00

Volume	59,405
Avg Vol	156,510
Day's Range	N/A - N/A
Shares Out	19.29M
Stochastic %K	66%
Beta	0.85
Analysts	Strong Sell
Price Target	$144.75